Correlations between Mortality-to-Incidence Ratios and Health Care Disparities in Testicular Cancer

The mortality-to-incidence ratio (MIR) is associated with the clinical outcomes of different types of cancer as well as the ranking of health care systems. However, the association between MIRs for testicular cancer and health care disparities, including differences in expenditures and health system...

Full description

Saved in:
Bibliographic Details
Published in:International journal of environmental research and public health 2019-12, Vol.17 (1), p.130
Main Authors: Chen, Wen-Jung, Huang, Cheng-Yu, Huang, Yu-Hui, Wang, Shao-Chuan, Hsieh, Tzuo-Yi, Chen, Sung-Lang, Sung, Wen-Wei, Lee, Tsung-Hsien
Format: Article
Language:English
Subjects:
Cancer
Correlation coefficient
Correlation coefficients
Developed countries
Ethnicity
Expenditures
Global Health
Gross Domestic Product
Health care
Health care expenditures
Health Expenditures
Healthcare Disparities
Humans
Incidence
Life expectancy
Male
Mortality
Ranking
Socioeconomic factors
Testes
Testicular cancer
Testicular Neoplasms - epidemiology
World Health Organization
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The mortality-to-incidence ratio (MIR) is associated with the clinical outcomes of different types of cancer as well as the ranking of health care systems. However, the association between MIRs for testicular cancer and health care disparities, including differences in expenditures and health system rankings, has not yet been reported. We used the Spearman's rank correlation coefficient (CC) to analyze the correlation between testicular cancer MIRs and both total expenditures on health/gross domestic product (e/GDP) and the World Health Organization's (WHO) health system rankings. After screening the data for quality and missing information, 57 countries were chosen for analysis. Generally, developed countries and regions had relatively high rates of incidence/mortality, but with a favorable MIR. Among the continents, Europe had the highest incidence rates, whereas the highest MIRs were in Africa. Globally, favorable testicular cancer MIRs were observed in countries with both a high e/GDP and a good WHO ranking (R = 0.325, < 0.001 and CC = -0.568, < 0.001; R = 0.367, < 0.001 and CC = 0.655, < 0.001, respectively). In conclusion, the MIR for testicular cancer varies in countries and regions based on both their total health expenditure and their health care system ranking.
ISSN:1660-4601
1661-7827
1660-4601
DOI:10.3390/ijerph17010130